Latest Business Development News

Bryah Resources has locked in $1.1 million through a two-tranche placement to fund its copper exploration efforts in the Bryah Basin and support ongoing business development.

RareX Limited's December 2024 Quarterly Report reveals significant progress in its Khaleesi Niobium and Mt Mansbridge Heavy Rare Earth projects, setting the stage for targeted drilling campaigns in 2025. The company also highlights strategic business development and sustainability initiatives.

BPH Global Limited secured $325,000 in funding during the December quarter, progressing its Indonesian seaweed venture and renewing key R&D partnerships. The company ends the quarter with $226,000 cash on hand and plans a $1 million capital raise at an upcoming EGM.

Cosmo Metals has made significant strides in its exploration programs at the Kanowna Gold Project and Yamarna Region, supported by a recent $500,000 capital raise via convertible notes. The company is strategically evaluating project opportunities to maximise stakeholder value.

Carly Holdings Limited has reported a 41% jump in customer receipts and its highest-ever subscription revenue in the December 2024 quarter, alongside significant cost reductions and strategic fleet adjustments.

FinTech Chain Limited reports a robust increase in cash balances and positive operating cash flow for Q3 2024, alongside new contract wins and ongoing legal proceedings related to a past misappropriation case.

8common Limited reports a record $1.2 million in SaaS revenue for Q2 FY25, driven by a 12% increase in users and strong government contract activity. Despite tight cash balances, the company remains funded through a chairman-backed facility.

Australian Vanadium Limited reports significant progress in its integrated vanadium supply chain, including government approvals, Project Lumina development, and successful vanadium flow battery deployment.

Careteq Limited reports solid progress in integrating its Embedded Health Solutions with HMR Referrals, alongside a 14% revenue increase and improved cash flow in Q2 FY25.

Optiscan Imaging Ltd reported a productive December quarter, marked by key product developments, strategic partnerships, and a stronger cash position, setting the stage for growth in medical and veterinary imaging markets.

Novatti Group Limited reports a robust December quarter with a 30% year-on-year revenue increase and a significant reduction in expenses, positioning the fintech on track for positive operating cashflow by mid-2025.

AdAlta Limited has bolstered its leadership team and progressed its 'East to West' cellular therapy strategy alongside its lead drug candidate AD-214, despite a tightening cash position. The company’s recent non-binding term sheet and new clinical data signal promising momentum in its biotech pipeline.